Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research.

Files

Dorward Jienchi_2018.pdf (73.99 KB)

Date

Authors

Dorward, Jienchi.

Lessells, Richard John.

Naidoo, Kogieleum.

De Oliveira, Tulio De Paiva Nazareth Andrade.

Abdool Karim, Salim Safurdeen.

Garrett, Nigel Joel.

Publisher

Elsevier.

Abstract

Abstract available in pdf.

Description

CAPRISA, 2018.

Keywords

HIV., Antiretroviral therapy., Dolutegravir., Viral load., Adherence., Resistance.

Citation

Dorward, J., Lessells, R., Drain, P.K., Naidoo, K., de Oliveira, T., Pillay, Y., Abdool Karim, S.S. and Garrett, N. 2018. Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research. Lancet HIV 5(7), e400-e404.

URI

http://dx.doi.org/10.1016/S2352-3018(18)30093-6
https://researchspace.ukzn.ac.za/handle/10413/16649

Collections

Research papers (Caprisa)